BMS posts last financials for medical imaging business

Pharmaceutical developer Bristol-Myers Squibb (BMS) has posted its 2007 fourth-quarter and year-end financial results (end-December 31), including results for the medical imaging division that it sold to venture capital firm Avista Capital Partners last month.

The New York City-based company presented results for the medical imaging business as a discontinued operation. Included in discontinued operations were fourth-quarter net sales of $142 million, down 10% compared to $156 million in sales in the same period of 2006.

For the full year, the company's discontinued operations produced sales of $629 million, down 5% compared with $658 million in the previous year, according to Bristol-Myers Squibb.

Related Reading

Avista completes Bristol-Myers Squibb buy, January 10, 2008

Bristol-Myers Squibb finds buyer for imaging unit, December 17, 2007

Bristol-Myers Squibb to divest imaging unit, including Cardiolite radiopharmaceutical, December 5, 2007

Bristol breast cancer drug aims at sickest women, October 16, 2007

Bristol-Myers Squibb boosts Q2 results, July 27, 2007

Copyright © 2008

Page 1 of 180
Next Page